Latest WEX Pharmaceuticals Inc. Stories
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 25, 2008) - WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX:WXI) announced today that Dr. Neil Hagen, the lead investigator for WEX's Phase III clinical trial of TTX, will make a presentation titled "Tetrodotoxin (TTX): From Poison to Medicine" at the IXth World Conference on Clinical Pharmacology and Therapeutics in Quebec City, Quebec on July 28. For more information, please see www.cpt2008.com. About TTX Tetrodotoxin (TTX), a...
- Boughs or branches.
- Warbling of birds in trees.